1-8 of 8
Thomas Ollila
Close
Sort by
Journal Articles

Correlation between PFS and OS in FL: Implications for Clinical Trial Endpoint Selection

Charles Milrod, Kang Woo Kim, Thomas Ollila, Adam J Olszewski, Ari Pelcovits
Journal: Blood
Blood (2023) 142 (Supplement 1): 4395.
https://doi.org/10.1182/blood-2023-177626
Published: 2023
Journal Articles

Alterations in Immune Cell Composition during First-Line Therapy with Mosunetuzumab for Follicular or Marginal Zone Lymphoma

Adam J Olszewski, Thomas Ollila, Ari Pelcovits, Anna Dorota Chorzalska, John Morgan, Jessica McMahon, Stephen Donnelly, Scott F. Huntington, Matthew Matasar, John L. Reagan, Charles Milrod, Patrycja M. Dubielecka
Journal: Blood
Blood (2023) 142 (Supplement 1): 1651.
https://doi.org/10.1182/blood-2023-181418
Published: 2023
Journal Articles

Immune Reconstitution and Infection Patterns Following CAR T-Cell Therapy in Patients with Aggressive Lymphoma

Megan Melody, Narendranath Epperla, Geoffrey P. Shouse, Jason T. Romancik, Tamara K. Moyo, Vaishalee P Kenkre, Thomas Ollila, Lindsey Fitzgerald, Brian Hess, Kevin A. David, Kaitlin Annunzio, Megan Herr, Rahul S. Bhansali, Elyse I Harris, James A Davis, Oluwatobi Odetola, Adam Yuh Lin, Jonathan Moreira, Shuo Ma, Jane N. Winter, Deborah M. Stephens, Alexey Danilov, Nirav N. Shah, Ishan Roy, Stefan K. Barta, Matthew J Cortese, Pallawi Torka, Jonathon B. Cohen, Leo I. Gordon, Reem Karmali
Journal: Blood
Blood (2023) 142 (Supplement 1): 1738.
https://doi.org/10.1182/blood-2023-183011
Published: 2023
Journal Articles

Exploration of Language As a Barrier to the Assessment and Management of CAR T-Cell Therapy Associated Toxicities

Megan Melody, Narendranath Epperla, Matthew J Cortese, Jason T. Romancik, Tamara K. Moyo, Vaishalee P Kenkre, Thomas Ollila, Lindsey Fitzgerald, Brian Hess, Kevin A. David, Kaitlin Annunzio, Megan Herr, Rahul S. Bhansali, Elyse I Harris, James A Davis, Oluwatobi Odetola, Adam Yuh Lin, Shuo Ma, Jonathan Moreira, Jane N. Winter, Deborah M. Stephens, Alexey Danilov, Nirav N. Shah, Jonathon B. Cohen, Geoffrey P. Shouse, Ishan Roy, Stefan K. Barta, Leo I. Gordon, Reem Karmali
Journal: Blood
Blood (2023) 142 (Supplement 1): 2407.
https://doi.org/10.1182/blood-2023-183041
Published: 2023
Journal Articles

A Multicenter Study Analyzing Survival and Prognostic Factors in Patients with Leukemic Phase Follicular Lymphoma

Asaad Trabolsi, Narendranath Epperla, Kaitlin Annunzio, Dan Morgenstern Kaplan, Peter Doukas, Frederique St-Pierre, Brittany McCall, Lindsey Fitzgerald, Sunwoo Han, Isildinha M. Reis, Jennifer Rose Chapman-Fredricks, Khaled Alhamad, Thomas Ollila, Reem Karmali, Izidore S. Lossos, Juan Pablo Alderuccio
Journal: Blood
Blood (2023) 142 (Supplement 1): 3770.
https://doi.org/10.1182/blood-2023-173905
Published: 2023
Journal Articles

Marrow Hypocellularity, but Not Residual Blast Count, Is Prognostic on Day-14 Assessment in Acute Myeloid Leukemia

Thomas Ollila, MD, Adam J Olszewski, MD, Peter J. Quesenberry, MD, Matthew I. Quesenberry, MD, James Butera, MD, John L. Reagan, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1428.
https://doi.org/10.1182/blood.V130.Suppl_1.1428.1428
Published: 2017
Journal Articles

Survival of Patients with Del(5q) Syndrome in the Lenalidomide Era

John L Reagan, MD, Thomas Ollila, MD, Patrycja M Dubielecka, PhD, Adam J Olszewski, MD
Journal: Blood
Blood (2016) 128 (22): 1994.
https://doi.org/10.1182/blood.V128.22.1994.1994
Published: 2016
Journal Articles

The Role of Day 14 Bone Marrow Analysis in Determining Leukemia Free Survival and Overall Survival

Thomas Ollila, MD, John L Reagan, MD, Jorge J Castillo, MD, James N Butera, MD, Eric S Winer, MD, Michael S Cardin, RPh
Journal: Blood
Blood (2015) 126 (23): 4974.
https://doi.org/10.1182/blood.V126.23.4974.4974
Published: 2015